First NIH Study on Prostatitis Is Initiated to Help Unravel Mysterious Condition Affecting Half of All Men in the U.S. FLOMAX(R) (tamsulosin HCL) and CIPRO(R) (ciprofloxacin) Chosen as Study Treatments in Combination and as Monotherapies.

PR Newswire | December 12, 2001 | Copyright

RIDGEFIELD, Conn. -- Boehringer Ingelheim Pharmaceuticals, Inc. announced today its involvement in the initiation of a National Institutes of Health (NIH) clinical trial on prostatitis, a pervasive and painful condition that impacts millions of men. The NIH decision to pursue this clinical research is significant because prostatitis, while affecting 50 percent of all men during their lifetime(1), is not well understood or studied, leading to difficulty diagnosing and treating the condition. The NIH multi-site, double-blinded, placebo-controlled, randomized study is the ...

Related newspaper, magazine, and trade journal articles from HighBeam Research

(Including press releases, facts, information, and biographies)

Milwaukee Seeks Buyer for Pabst Complex.
Newspaper article from: Knight Ridder/Tribune Business News ; ...Ave., W. Winnebago St., N. 8th St. and N. 11th St. Polacheck...the original corner office of beer baron Frederick Pabst, whose namesakes include the...east side for The Blatz and just north of downtown along the Milwaukee River...
Tapping history
Newspaper article from: The Milwaukee Journal Sentinel ; ...Ave., W. Winnebago St., N. 8th St. and N. 11th St. Polacheck...the original corner office of beer baron Frederick Pabst, whose namesakes include the...east side for The Blatz and just north of downtown along the Milwaukee River...

Find more facts and information related to the article "First NIH Study on Prostatitis Is Initiated to ..."